The research findings showed that BMSC-EVs increased the survival rate of cardiomyocytes, increased the expression of vWF and VEGF, and activated the Akt/Nrf2/HO-1 pathway, resulting in overall improvements in outcomes for myocardial infarction (MI). The gene discussed is NFE2L2; the disease is myocardial infarction.